Limited Competition for the Continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) (U01)
The summary for the Limited Competition for the Continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for the Continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) (U01): Purpose. The purpose of this Limited Competition is to invite applications from the participating clinical sites and the Data Coordinating and Imaging Analysis Center (DCIAC) that have participated in the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) clinical study, and therefore have continued access to the cohort of patients and the data from the prospective observational study of polycystic kidney disease (PKD).The primary objectives of this initiative are to continue follow-up of the well-characterized and highly motivated CRISP patient and to provide a platform for informative ancillary studies. Mechanism of Support. This FOA will utilize the NIH cooperative agreement (U01)award mechanism. Funds Available and Anticipated Number of Awards. The NIDDK intends to commit approximately $1,500,000 in Fiscal Year2011 to fund three participating clinical centers and one DCIAC in response to this Limited Competition. Budget and Project Period.An applicant may request up to $225,000 direct costs per year for up to five years. Application Research Strategy Length: The U01 Research Strategy section may not exceed 12 pages, including tables, graphs, figures, diagrams, and charts. See Table of Page Limits. Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply. Eligible Project Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Federal Grant Title: | Limited Competition for the Continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Food and Nutrition Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DK-10-501 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Digestive, and Kidney Diseases Extramural Research |
Current Application Deadline: | Jun 30, 2010 |
Original Application Deadline: | Jun 30, 2010 |
Posted Date: | Mar 17, 2010 |
Creation Date: | Mar 17, 2010 |
Archive Date: | Jul 31, 2010 |
Total Program Funding: | $1,500,000 |
Maximum Federal Grant Award: | $225,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Only institutions that received an award under CRISP II are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
- • Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
- • Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
- • NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
- • NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)